DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Supplement Amino Acid

Information source: Pennington Biomedical Research Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Growth Hormone; Amino Acid

Intervention: Amino acid supplement (Drug); Placebo (Drug)

Phase: N/A

Status: Completed

Sponsored by: Pennington Biomedical Research Center


The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

Clinical Details

Official title: Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.

Study design: Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Primary outcome: Quantity of Growth Hormone

Secondary outcome: Insulin-like growth factor 1

Detailed description: Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.


Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.


Inclusion Criteria:

- 12 healthy males and 4 healthy females

- Between 18 and 70 years

Exclusion Criteria:

- Pregnant or nursing

- Taking any chronic medication including birth control pills.

Locations and Contacts

Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, United States
Additional Information

Starting date: October 2011
Last updated: June 6, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017